See also this year's filing and all EDGAR filings for this company.
PDF Report 0001615219_2023_Salarius_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001615219, Salarius Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 14,520,298 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 130,501 |
| 4 | LiabilitiesCurrent | 2,858,330 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,407,861 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,138,403 |
| 9 | ResearchAndDevelopmentExpense | 15,836,828 |
| 10 | remainder_Expenses | 8,851,455 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 218,730 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 14,650,799 |
| 1 | Liabilities | 4,266,191 |
| 2 | Expenses | 31,826,686 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 10,384,608 |
| 5 | NetIncome | -31,607,956 |
| 6 | ComprehensiveNetIncome | -31,607,956 |
| 7 | BaseVar | 25,481,203 |
| 8 | EconomicCapitalRatio | -1.45 |
Edgar->Model Mapping
Feature Distribution
Change over Time
